106 related articles for article (PubMed ID: 2819470)
1. Characterization of glucagon-like peptide-1-(7-36)amide in the hypothalamus.
Kreymann B; Ghatei MA; Burnet P; Williams G; Kanse S; Diani AR; Bloom SR
Brain Res; 1989 Nov; 502(2):325-31. PubMed ID: 2819470
[TBL] [Abstract][Full Text] [Related]
2. Isolation and characterisation of GLP-1 7-36 amide from rat intestine. Elevated levels in diabetic rats.
Kreymann B; Yiangou Y; Kanse S; Williams G; Ghatei MA; Bloom SR
FEBS Lett; 1988 Dec; 242(1):167-70. PubMed ID: 3203741
[TBL] [Abstract][Full Text] [Related]
3. Developmental patterns of glucagon-like peptide-1-(7-36) amide and peptide-YY in rat pancreas and gut.
Kreymann B; Ghatei MA; Domin J; Kanse S; Bloom SR
Endocrinology; 1991 Aug; 129(2):1001-5. PubMed ID: 1677327
[TBL] [Abstract][Full Text] [Related]
4. Structural characterization by affinity cross-linking of glucagon-like peptide-1(7-36)amide receptor in rat brain.
Calvo JC; Yusta B; Mora F; Blázquez E
J Neurochem; 1995 Jan; 64(1):299-306. PubMed ID: 7798926
[TBL] [Abstract][Full Text] [Related]
5. Identification and characterization of glucagon-like peptide-1 7-36 amide-binding sites in the rat brain and lung.
Kanse SM; Kreymann B; Ghatei MA; Bloom SR
FEBS Lett; 1988 Dec; 241(1-2):209-12. PubMed ID: 2848722
[TBL] [Abstract][Full Text] [Related]
6. Reduced insulinotropic effects of glucagonlike peptide I-(7-36)-amide and gastric inhibitory polypeptide in isolated perfused diabetic rat pancreas.
Suzuki S; Kawai K; Ohashi S; Mukai H; Murayama Y; Yamashita K
Diabetes; 1990 Nov; 39(11):1320-5. PubMed ID: 2146178
[TBL] [Abstract][Full Text] [Related]
7. Identification and localization of glucagon-like peptide-1 and its receptor in rat brain.
Shimizu I; Hirota M; Ohboshi C; Shima K
Endocrinology; 1987 Sep; 121(3):1076-82. PubMed ID: 3040376
[TBL] [Abstract][Full Text] [Related]
8. Identification of glucagon-like peptide-1(7-36) amide in rat brain.
Yoshimoto S; Hirota M; Ohboshi C; Shima K
Ann Clin Biochem; 1989 Mar; 26 ( Pt 2)():169-71. PubMed ID: 2729860
[TBL] [Abstract][Full Text] [Related]
9. Release of glucagon-like peptide 1 immunoreactivity from the perfused rat pancreas.
Shima K; Hirota M; Ohboshi C; Sato M; Nishino T
Acta Endocrinol (Copenh); 1987 Apr; 114(4):531-6. PubMed ID: 3577586
[TBL] [Abstract][Full Text] [Related]
10. Distribution and molecular forms of glucagon-like peptide in the dog.
Suda K; Takahashi H; Fukase N; Manaka H; Tominaga M; Sasaki H
Life Sci; 1989; 45(19):1793-8. PubMed ID: 2593768
[TBL] [Abstract][Full Text] [Related]
11. Molecular forms of glucagon-like peptide-1 in human pancreas and glucagonomas.
Uttenthal LO; Ghiglione M; George SK; Bishop AE; Polak JM; Bloom SR
J Clin Endocrinol Metab; 1985 Sep; 61(3):472-9. PubMed ID: 2991321
[TBL] [Abstract][Full Text] [Related]
12. Identification of amidated forms of GLP-1 in rat tissues using a highly sensitive radioimmunoassay.
van Delft J; Uttenthal LO; Hermida OG; Fontela T; Ghiglione M
Regul Pept; 1997 Jun; 70(2-3):191-8. PubMed ID: 9272633
[TBL] [Abstract][Full Text] [Related]
13. Regulation of pancreatic PC1 and PC2 associated with increased glucagon-like peptide 1 in diabetic rats.
Nie Y; Nakashima M; Brubaker PL; Li QL; Perfetti R; Jansen E; Zambre Y; Pipeleers D; Friedman TC
J Clin Invest; 2000 Apr; 105(7):955-65. PubMed ID: 10749575
[TBL] [Abstract][Full Text] [Related]
14. Central administration of glucagon-like peptide-1 activates hypothalamic neuroendocrine neurons in the rat.
Larsen PJ; Tang-Christensen M; Jessop DS
Endocrinology; 1997 Oct; 138(10):4445-55. PubMed ID: 9322962
[TBL] [Abstract][Full Text] [Related]
15. Central infusions of leptin and GLP-1-(7-36) amide differentially stimulate c-FLI in the rat brain.
Van Dijk G; Thiele TE; Donahey JC; Campfield LA; Smith FJ; Burn P; Bernstein IL; Woods SC; Seeley RJ
Am J Physiol; 1996 Oct; 271(4 Pt 2):R1096-100. PubMed ID: 8898006
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the effects of various C-terminal and N-terminal fragment peptides of glucagon-like peptide-1 on insulin and glucagon release from the isolated perfused rat pancreas.
Suzuki S; Kawai K; Ohashi S; Mukai H; Yamashita K
Endocrinology; 1989 Dec; 125(6):3109-14. PubMed ID: 2684616
[TBL] [Abstract][Full Text] [Related]
17. Regulation of glucagon-like peptide-1-(7-36) amide, peptide YY, and neurotensin secretion by neurotransmitters and gut hormones in the isolated vascularly perfused rat ileum.
Dumoulin V; Dakka T; Plaisancie P; Chayvialle JA; Cuber JC
Endocrinology; 1995 Nov; 136(11):5182-8. PubMed ID: 7588257
[TBL] [Abstract][Full Text] [Related]
18. Tissue and plasma concentrations of amidated and glycine-extended glucagon-like peptide I in humans.
Orskov C; Rabenhøj L; Wettergren A; Kofod H; Holst JJ
Diabetes; 1994 Apr; 43(4):535-9. PubMed ID: 8138058
[TBL] [Abstract][Full Text] [Related]
19. Cellular localization of proglucagon/glucagon-like peptide I messenger RNAs in rat brain.
Han VK; Hynes MA; Jin C; Towle AC; Lauder JM; Lund PK
J Neurosci Res; 1986; 16(1):97-107. PubMed ID: 2427741
[TBL] [Abstract][Full Text] [Related]
20. Glucagon-like peptide-1(7-36)amide induces the release of aspartic acid and glutamine by the ventromedial hypothalamus of the conscious rat.
Calvo JC; Gisolfi CV; Blazquez E; Mora F
Brain Res Bull; 1995; 38(5):435-9. PubMed ID: 8665266
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
